20,000
Participants
Start Date
January 31, 2016
Primary Completion Date
April 6, 2017
Study Completion Date
April 6, 2017
suPAR measurement
The biomarker suPAR will be measured on all patients included in the study. Before the study period the doctors will receive information on suPAR. We want to study if the information provided by suPAR is useful in emergency medicine. Interventions depends on the clinical issue, as suPAR is an unspecific marker of disease. Usually a elevated suPAR level could result in more investigation e.g. diagnostic procedures or follow up, while a low suPAR could result in faster discharge.
Herlev Hospital, Department of Cardiology, Herlev
Herlev Hospital
OTHER